Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.

Jacobson, J M

Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. [electronic resource] - The Journal of infectious diseases Jul 1999 - 61-7 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.

0022-1899

10.1086/314834 doi


Acquired Immunodeficiency Syndrome--complications
Adult
Antigens, CD--analysis
Double-Blind Method
Esophageal Diseases--complications
Ethnicity
Female
HIV Infections--complications
Humans
Male
Placebos
Quality of Life
Receptors, Tumor Necrosis Factor--analysis
Receptors, Tumor Necrosis Factor, Type II
Stomatitis, Aphthous--drug therapy
Thalidomide--adverse effects
Tumor Necrosis Factor-alpha--analysis
Ulcer--complications
United States